Navigation Links
Response Genetics Reports Second Quarter 2007 Financial Results
Date:8/19/2007

LOS ANGELES, Aug. 14 /PRNewswire-FirstCall/ -- Response Genetics, Inc. (Nasdaq: RGDX), today reported financial results for the second quarter ended June 30, 2007.

"The second quarter of 2007 was very exciting for Response Genetics, beginning with our successful initial public offering in June," said Kathleen Danenberg, President and CEO of Response Genetics. "We are very pleased by the recent developments that have since been announced. During the quarter these developments include our collaborations with Hitachi Chemical and the University of California, San Francisco, and the publication of clinical data in the Journal of Clinical Oncology that support the use of diagnostic screening for lung cancer patients. We believe these developments further validate our business strategy of using genetic information to develop diagnostic tests which will help physicians tailor treatment to the individual patient."

Financial Results for Three Months Ended June 30, 2007

Total revenue increased to $1.5 million in the second quarter of 2007 compared to $738,150 in the second quarter of 2006. This increase was primarily due to the introduction of new testing services being offered by Response Genetics to its pharmaceutical clients, and the Company's existing pharmaceutical contracts related to pharmacogenomic testing services.

Cost of revenue for the second quarter of 2007 was $1.2 million, compared with $584,230 for the second quarter of 2006. Research and development expenses were $916,793 for the second quarter of 2007, compared with $269,247 for the same period in the prior year. General and administrative expenses of $1.9 million for the second quarter of 2007 increased from $659,246 for the second qua
'/>"/>

SOURCE Response Genetics, Inc.

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system
2. FLIPR Calcium 3 Assay Kit - An Optimal No-Wash Fluorescence Calcium Indicator Reagent for Non-Optimal Calcium Responses
3. IT critical in pandemic response, but many are not paying attention
4. Quick response manufacturing and biotech
5. Wisconsin court affirms damages in Innogenetics, Abbott patent case
6. Third Wave licenses Innogenetics tech to settle lawsuit
7. Symposium examines the effect of race on genetics and disease
8. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
9. Sonic Foundry reports GAAP loss as Q2 revenues rise
10. Fiserv reports $113.5 million in Q1 profit
11. Third Wave reports net loss of $18.9M for 2006

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...ITY,Calif.,Nov.23/PRNewswire/--PearlTherapeuticsIn...roductsforthetreatmentofchronicrespiratorydiseases...any,sBoardofDirectors.Mr.Rosenhas25yearsofexperien...cludingkeyrolesatGileadSciencesandALZACorporation....,sBoardtosix. ,, "Howiebringsawealthofproductde...
(Date:11/20/2009)...TLE, Nov. 20 Dendreon Co...e U.S. Food and Drug Administration (FDA) provided...d Biologics License Application (BLA) for PROVENGE... FDA has assigned a Prescription Drug User Fee Act...l respond to Dendreon,s amended BLA. Dendreon is ...
(Date:11/20/2009)... METTLER TOLEDO recently announced that D... “The Role of Process Analytical Technology ...uo; on December 1, 2009. , ...e of Process Analytical Technology (PAT) in Green ...er 1, Process Analytical Technology (PAT) case stu...
(Date:11/19/2009)... ,, BETHESDA, Md., Nov. 19 /PRNewswire-FirstCal...novator in biotechnology for diabetes therapy, and... services to food, supplement, biotechnology and p... the previously reported $6.3 million registered d...0,870 shares of its common stock and warrants to p...
Breaking Biology Technology:Pearl Therapeutics Appoints Howie Rosen to Board of Directors 2Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3
...ALGARY, April 23 /PRNewswire-FirstCall/ - Oncolyti...CY) announced today that Prof. Alan,Melcher and hi...l in Leeds,U.K. published the results of their wor... The Journal of Immunology. The paper is entitled ...te Innate Antitumor Immunity.", The researchers s...
...atest version provides ,out-of-box, integrated rep...te manufacturers using SAP(R) ERP, ATLANTA, April...ecution systems (MES) for the integrated enterpris...prise ERP Shop Floor,Integration 2.0. A packaged c...acturing Integration and Intelligence (SAP MII) ap...
...REENVILLE, S.C., April 23 Signalife, Inc.,(Amex: ... and Trademark,Office has awarded the Company a ne...ethod Of, Monitoring Heartbeats Of A Patient". The...Company,s ability to develop new,proprietary produ...ervised and executed the,patent application along ...
Other Biology Technology:Oncolytics Biotech Inc. Announces Journal of Immunology Publication on Reovirus Activation of Dendritic Cells 2Visiprise Enhances Its Shop Floor Integration Solution for Manufacturers 2Visiprise Enhances Its Shop Floor Integration Solution for Manufacturers 3Visiprise Enhances Its Shop Floor Integration Solution for Manufacturers 4Signalife Awarded New U.S. Patent, 'System For, And Method Of, Monitoring Heartbeats Of A Patient' 2
(Date:11/23/2009)...rlos Mara Romeo Casabona is Director of the Interu...me at Deusto University and the University of the ...up of jurists but also has other experts such as r...icine and even specialists in ethics. , The Inte...nome at the Universities of Deusto and the Basque ...
(Date:11/22/2009)...NCINNATI -- Children exposed prenatally to tobacco...larly high risk for ADHD, according to research do...r. , The study estimates that up to 35 percent o... 15 could be reduced by eliminating both of these ... up to 800,000 children , "Tobacco and lead exp...
(Date:11/22/2009)...Cambridge, MA November 23, 2009 Agios Pharmaceut...ablished, for the first time, that the mutated IDH... a cancer-causing gene, or oncogene. This breakthr... produces a metabolite, 2-hydroxyglutarate (2HG), ...t progression of gliomas, the most common type of ...
Breaking Biology News(10 mins):Research and legislation should go hand in hand, as much as possible 2Exposure to lead, tobacco smoke raises risk of ADHD 2Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 2Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 3Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 4A Dementia That Afflicts Younger Population Has Similarities to Alzheimers Applicable Treatments 57781 1A Dementia That Afflicts Younger Population Has Similarities to Alzheimers Applicable Treatments 57781 2A Dementia That Afflicts Younger Population Has Similarities to Alzheimers Applicable Treatments 57781 3A Dementia That Afflicts Younger Population Has Similarities to Alzheimers Applicable Treatments 57781 4New Website Offers Free Tool Designed to Help Patients Speak Up 57779 1New Website Offers Free Tool Designed to Help Patients Speak Up 57779 2Cadient Group Selected as Finalist in Medical Marketing 26 Media Awards 14180 1Cadient Group Selected as Finalist in Medical Marketing 26 Media Awards 14180 2
... CORVALLIS, Ore. The catastrophic fires that are ...hat climate change models have been predicting for...e to many more such events in the future as veget...ring prolonged drought periods. , This is exactly...t-term fire forecasts for this year and the longer...
... When prehistoric fish made their first forays ont...blished in the online open access journal, BMC Evo...uring out of the depths viewed their new environme...at the School of Biomedical Sciences, University o...s from Australian lungfish (Neoceratodus forsteri)...
... STANFORD, Calif. - Previously hidden obesity-rela... by researchers at the Stanford University School .... The finding suggests that useful information abo...untains of discarded data. , "We,ve devised a fai...g raw data into candidate disease genes for furthe...
Other Biology News:Massive California fires consistent with climate change 2Stanford/Packard researchers find disease genes hidden in discarded data 2Stanford/Packard researchers find disease genes hidden in discarded data 3
Bovine Bovine Serum Albumin, Alexa Fluor 680 conjugated/tagged from Molecular Probes (Invitrogen)
...abbit Reticulocyte Lysate contains the cellular co...bosomes, amino acids, initiation, elongation and t...micrococcal nuclease. Untreated Lysate is used pri...s an abundant source of endogenous globin mRNA. Un...
Rat Anti-Mouse Macrophages, Metallophilic Monoclonal Antibody, Unconjugated from AbD Serotec
Coverslips for Microarrays from GE Healthcare, formerly Amersham Biosciences
Biology Products: